Related Experiment Video
Updated: Jun 25, 2026
12:57
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Properties and pathogenicity of prion-derived peptides
1Department of Physiology & Biochemistry, University of Malta, Msida MSD 2080, Malta. neville.vassallo@um.edu.mt
Protein and Peptide Letters
|March 12, 2009
Summary
Prion diseases involve misfolded prion proteins (PrPSc). Synthetic prion peptides mimic PrPSc, aiding research into neurodegeneration and developing therapies against prion-related disorders.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Prion diseases are neurodegenerative disorders caused by misfolded prion protein (PrPC to PrPSc).
- The heterogeneous nature of PrPSc aggregates complicates studying prion diseases.
- Prion-derived peptides offer a simplified model for investigating prion pathogenesis.
Purpose of the Study:
- To explore the relationship between amino acid sequence, structure, and biological effects of prion-derived peptides.
- To understand the mechanisms of neurotoxicity induced by prion peptides.
- To establish the utility of prion peptides in developing therapeutic strategies.
Main Methods:
- Utilizing synthetic prion-derived peptides (e.g., PrP(106-126), PrP(118-135)).
- Analyzing peptide structure, including beta-sheet content.
- Assessing peptide effects on lipid membranes, calcium regulation, oxidative stress, and apoptotic pathways.
- Evaluating in vivo toxicity of prion peptides.
Main Results:
- Prion peptides replicate key features of full-length PrPSc, including beta-sheet structure and membrane destabilization.
- Peptides induce intracellular calcium dysregulation, oxidative stress, and pro-apoptotic signaling.
- In vivo toxicity of specific prion peptides (PrP(106-126), PrP(118-135)) has been confirmed.
- Neurotoxicity is, in some cases, dependent on endogenous PrPC expression.
Conclusions:
- Prion-derived peptides serve as valuable tools for studying prion disease mechanisms.
- These peptides facilitate the development of therapeutic strategies targeting prion aggregation and neurotoxicity.
- Pharmacological agents protecting against peptide-induced toxicity are promising for treating prion diseases.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:20Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
02:18The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...